Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announced that the U.S. Food and Drug Administration (FDA) has approved its generic version of Eli Lilly and Company’s Evista (60 mg). Evista is indicated for the prevention and treatment of osteoporosis in postmenopausal women and reduction of the risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk of invasive breast cancer. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock opened at $49.31 in last session, and closed at $49.80, while the day range of stock is $49.28 – $50.28. The stock showed a positive weekly performance of 3.41%.
Dynavax Technologies Corporation (NASDAQ:DVAX) recently received a $5.4 million milestone payment from collaboration partner AstraZeneca. Dynavax Technologies Corporation (NASDAQ:DVAX) stock opened at $1.98, in last session and closed at $2.04, by gaining 2.51%. The 52 week range of the stock is $0.98 – $2.68. Company’s market capitalization is $535.76 million.
Analysts at UBS AG increased their price objective on shares of Endo Health Solutions (NASDAQ:ENDP) from $75.00 to $90.00 in a research report issued to clients and investors on Monday, AnalystRatings.Net reports. The firm currently has a “buy” rating on the stock. Endo Health Solutions Inc (NASDAQ:ENDP) stock decreased -1.94% and finished the last session at $76.47. The EPS of the stock remained -5.58. Company’s market capitalization is $8.84 billion.
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced in a press release that the Food and Drug Administration (FDA) awarded marketing exclusivity to Vascepa (icosapent ethyl) capsules. The three year exclusivity stems from 2012 approval of Vascepa. Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock opened the session at $1.76, and closed the session at $1.80. The 52 week range of the stock remained $1.36 – $8.77 and the day range was $1.72 – $1.80.